Drug Trial Radar · NCT03940391
Effect of the Antihistamine Injection to Prevent Paradoxical Reaction During Sedative Endoscopy
Last checked: Nov 20, 2026Latest source record: Apr 17, 2020 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Status unknown
Enrollment
220
Planned (sponsor's estimate)
Start
May 1, 2019
Primary completion
Apr 14, 2020
Study completion Apr 14, 2020
Sponsor
- Lead sponsor
- Seoul National University HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- First posted
- May 7, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable
- Allocation
- Non randomized
- Model
- Parallel
- Masking
- Single (investigator)
- Primary purpose
- Prevention
- FDA-regulated drug
- No
- Who can join
- All sexes, from 19 years, up to 69 years
- Healthy volunteers
- Yes
Summary
As written by the sponsor on the registry.
This single-blind prospective study is aimed to investigate the effect of antihistamine as an adjunctive sedative for the patients with histories of severe paradoxical reaction to midazolam during sedative endoscopy. Participating patients are to receive antihistamine intravenously in addition to midazolam. The primary outcome is the reduction of paradoxical reaction in the antihistamine combination group. The secondary outcome is to compare sedation quality, performance quality, reduction of total midazolam dose will be analyzed between antihistamine combination and midazolam only group.
Conditions
- Endoscopy
Interventions
Chlorpheniramine and midazolamDrug
Administration of chlorpheniramine injection as an adjunctive sedative during sedative endoscopy.
MidazolamDrug
Administration of midazolam as a sedative during sedative endoscopy as routine clinical practice.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Occurrence of severe paradoxical reaction (>= level 3)Time frame: 1 day
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Healthcare System Gangnam Center, Seoul National University Hospital
Seoul, South Korea
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.